Difficulty: Medium
Average Score: 76%
Practice
A 19-year-old college student man presents to the student health service with a 2-week history of headache, malaise, sore throat, and dry cough, which has become productive over the last 4 days. He states that several of his dorm mates have complained of similar problems in the last few weeks. Pulmonary auscultation reveals scattered coarse rhonchi bilaterally. What is the best treatment for this patient?
Correct answer
C
Rationale
In this scenario, the best treatment option for the 19-year-old college student with respiratory symptoms consistent with community-acquired pneumonia is oral erythromycin (Option C). Erythromycin is a macrolide antibiotic effective against the typical pathogens causing community-acquired pneumonia, such as Mycoplasma pneumoniae and Chlamydophila pneumoniae.
Option A, Cephazolin, is a cephalosporin antibiotic typically used for gram-positive bacterial infections, not the atypical pathogens commonly associated with community-acquired pneumonia. Option B, Ciprofloxacin, is a fluoroquinolone effective against gram-negative bacteria but not the preferred choice for community-acquired pneumonia.
In this educational context, understanding the appropriate selection of antibiotics based on the likely causative pathogens in pneumonia is crucial for effective treatment. Educating healthcare providers on the spectrum of activity of different antibiotics helps in making informed decisions to optimize patient outcomes and prevent antibiotic resistance. It is important to consider patient age, clinical presentation, and likely pathogens when choosing the most appropriate antibiotic therapy.
Option A, Cephazolin, is a cephalosporin antibiotic typically used for gram-positive bacterial infections, not the atypical pathogens commonly associated with community-acquired pneumonia. Option B, Ciprofloxacin, is a fluoroquinolone effective against gram-negative bacteria but not the preferred choice for community-acquired pneumonia.
In this educational context, understanding the appropriate selection of antibiotics based on the likely causative pathogens in pneumonia is crucial for effective treatment. Educating healthcare providers on the spectrum of activity of different antibiotics helps in making informed decisions to optimize patient outcomes and prevent antibiotic resistance. It is important to consider patient age, clinical presentation, and likely pathogens when choosing the most appropriate antibiotic therapy.